Latest Breaking News On - Stonepine capital management - Page 10 : vimarsana.com

James M Frates Sells 1,792 Shares of Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Stock

James M Frates Sells 1,792 Shares of Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesNova scotiaJamesm fratesRobertw bairdAmylyx pharmaceuticalsGoldman sachs groupAmylyx pharmaceuticals price performanceBlackrock incAmylyx pharmaceuticals incVanguard group incInstitutional investors weigh in on amylyx pharmaceuticalsStonepine capital managementNews ratings for amylyx pharmaceuticals dailyQuarter for amylyx pharmaceuticalsGet free reportCapital management

Gina Mazzariello Sells 1,540 Shares of Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) insider Gina Mazzariello sold 1,540 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $18.73, for a total value of $28,844.20. Following the completion of the sale, the insider now directly owns 81,372 shares of […]

United statesNova scotiaGina mazzarielloMarshall waceBlackrock incGoldman sachs groupInstitutional investors weigh in on amylyx pharmaceuticalsDeutsche bank aktiengesellschaftAmylyx pharmaceuticals company profileAmylyx pharmaceuticals incQuarter for amylyx pharmaceuticalsStonepine capital managementAmylyx pharmaceuticalsAmylyx pharmaceuticals trading downVanguard group incSecurities exchange commission

Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) CFO Sells $33,564 16 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) CFO James M. Frates sold 1,792 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $18.73, for a total transaction of $33,564.16. Following the completion of the transaction, the chief financial officer now owns 134,784 […]

United statesNova scotiaJamesm fratesRobertw bairdMarshall waceBlackrock incAmylyx pharmaceuticals incAmylyx pharmaceuticals company profileDeutsche bank aktiengesellschaftInstitutional investors weigh in on amylyx pharmaceuticalsStonepine capital managementQuarter for amylyx pharmaceuticalsAmylyx pharmaceuticalsAmylyx pharmaceuticals trading downVanguard group incNews ratings for amylyx pharmaceuticals daily

Rezolute, Inc (NASDAQ:RZLT) CFO Daron Evans Buys 50,000 Shares

Rezolute, Inc (NASDAQ:RZLT) CFO Daron Evans Buys 50,000 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDaron evansStonepine capital managementHermes incFirst manhattan coSecurities exchange commissionRezolute company profileNantahala capital managementRezolute incVivo capitalGet free reportExchange commissionCapital managementRezolute daily

Avidity Partners Management LP Decreases Holdings in SCYNEXIS, Inc (NASDAQ:SCYX)

Avidity Partners Management LP cut its holdings in shares of SCYNEXIS, Inc. (NASDAQ:SCYX – Free Report) by 24.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,319,444 shares of the company’s stock after selling 419,290 shares during the quarter. Avidity Partners Management LP owned […]

United statesBlackrock incVanguard group incA davidsonCompany profileCantor fitzgeraldScynexis incWorth venture partnersStonepine capital managementAvidity partners managementFree reportPartners managementCapital managementVenture partnersVisit holdingschannel